SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging

Robinson, SP; Kalber, TL; Howe, FA; McIntyre, DJ; Griffiths, JR; Blakey, DC; Whittaker, L; Ryan, AJ; Waterton, JC (2005) Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging. NEOPLASIA, 7 (5). 466 - 474 (9). ISSN 1522-8002 https://doi.org/10.1593/neo.04622
SGUL Authors: Howe, Franklyn Arron

Full text not available from this repository.
Item Type: Article
Additional Information: PubMed ID: 15967099
Keywords: Science & Technology, Life Sciences & Biomedicine, Oncology, ZD6126, vascular-targeting agents, MRI, tumor perfusion, response biomarker, VASCULAR-TARGETING AGENT, DIMETHYLARGININE DIMETHYLAMINOHYDROLASE, ANTIVASCULAR AGENT, COMBRETASTATIN A-4, MODEL SYSTEMS, BLOOD-FLOW, CANCER, ANGIOGENESIS, THERAPY, Animals, Antineoplastic Agents, Benzimidazoles, Female, Hemoglobins, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Microscopy, Fluorescence, Neoplasms, Organophosphorus Compounds, Perfusion, Prognosis, Prolactinoma, Rats, Rats, Wistar, Time Factors, ZD6126, vascular-targeting agents, MRI, tumor perfusion, response biomarker
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Neuroscience (INCCNS)
Journal or Publication Title: NEOPLASIA
ISSN: 1522-8002
Related URLs:
Dates:
DateEvent
1 May 2005Published
Web of Science ID: WOS:000229620100004
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: https://openaccess.sgul.ac.uk/id/eprint/226
Publisher's version: https://doi.org/10.1593/neo.04622

Actions (login required)

Edit Item Edit Item